Live Status Check

NCT04092673 Recruiting Status

Real-time enrollment status for this breast cancer clinical trial

Current Status

Recruiting

Auto-verified from ClinicalTrials.gov

Checked: March 2, 2026 at 10:16 AM UTC

NCT04092673 Status Summary

NCT NumberNCT04092673
Recruiting StatusRecruiting
ConditionBreast Cancer
PhaseClinical Trial
Target Enrollment30 participants
Active Locations14 sites in the US
SponsorEffector Therapeutics
Last Updated on CT.govMay 21, 2024 (May 21, 2024)

About NCT04092673 Enrollment Status

As of March 2, 2026: Clinical trial NCT04092673 is currently recruiting participants. This clinical trial study for breast cancer is actively seeking new participants at 14 locations across the United States. The study is sponsored by Effector Therapeutics. This status information is automatically verified from the official ClinicalTrials.gov registry.

Frequently Asked Questions About NCT04092673

Is NCT04092673 still recruiting?

Yes, NCT04092673 is actively recruiting participants as of March 2, 2026. You can check eligibility and apply through HelloStudys.

Where is NCT04092673 recruiting?

This trial is recruiting at 14 locations in the United States. View all available locations on the full study page.

How do I enroll in NCT04092673?

Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.

When was NCT04092673 status last updated?

The official ClinicalTrials.gov record for NCT04092673 was last updated May 21, 2024 (May 21, 2024). HelloStudys verifies this status automatically.

Ready to Apply?

Check your eligibility for this clinical trial